Document is current

Any future updates will be listed below

Uterusmalignome: Neue Immuntherapien bereichern den klinischen Alltag

Crossref DOI link: https://doi.org/10.1007/s15015-022-3830-2

Published Online: 2022-04-05

Published Print: 2022-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark